TABLE 1.
Demographic and risk factor characteristics by LC n–3 PUFA intake in controls (n = 2055)1
| Tertile of LC n–3 PUFA intake |
|||
| First (n = 685) | Second (n = 685) | Third (n = 685) | |
| Nutrient intake, % of total energy intake | |||
| LC n–3 PUFAs | 0.07 ± 0.022 | 0.12 ± 0.01 | 0.25 ± 0.13 |
| EPA | 0.02 ± 0.01 | 0.03 ± 0.01 | 0.07 ± 0.06 |
| DPA | 0.02 ± 0.01 | 0.03 ± 0.01 | 0.04 ± 0.01 |
| DHA | 0.03 ± 0.01 | 0.06 ± 0.01 | 0.14 ± 0.08 |
| Fish intake, g/d | 6.88 ± 5.90 | 14.12 ± 6.19 | 31.62 ± 19.73 |
| Adipose tissue LC n–3 PUFAs, % of total fatty acids | 0.35 ± 0.10 | 0.36 ± 0.10 | 0.39 ± 0.11 |
| Genotype, n (%) | |||
| rs11206510 TT | 549 (80.15) | 518 (75.62) | 538 (78.54) |
| rs11206510 TC | 129 (18.83) | 160 (23.36) | 132 (19.27) |
| rs11206510 CC | 7 (1.02) | 7 (1.02) | 15 (2.19) |
| Age,3 y | 59.32 ± 11.01 | 57.62 ± 11.76 | 58.01 ± 11.16 |
| Sex,3 F, n (%) | 218 (31.82) | 157 (22.92) | 170 (24.82) |
| Urban residence,3 n (%) | 247 (36.06) | 266 (38.83) | 295 (43.07) |
| Waist:hip ratio | 0.94 ± 0.07 | 0.95 ± 0.08 | 0.96 ± 0.08 |
| Alcohol consumption, g/d | 5.51 ± 15.3 | 5.90 ± 13.27 | 6.91 ± 14.76 |
| Current smoker, n (%) | 157 (23.05) | 156 (22.77) | 132 (19.41) |
| Aspirin use, n (%) | 106 (15.47) | 122 (17.81) | 118 (17.23) |
| Physical activity, METs/wk | 36.18 ± 17.36 | 36.02 ± 16.45 | 34.47 ± 14.39 |
| Family history of MI, n (%) | 47 (6.86) | 46 (6.72) | 56 (8.18) |
| History of diabetes, n (%) | 102 (14.93) | 96 (14.01) | 93 (13.58) |
| History of hypertension, n (%) | 199 (29.14) | 210 (30.7) | 205 (29.93) |
| History of hypercholesterolemia, n (%) | 181 (26.50) | 183 (26.79) | 188 (27.45) |
| Individual European admixture proportion, % | 57.36 ± 7.54 | 57.11 ± 7.84 | 58.71 ± 8.43 |
| Total energy intake, kcal/d | 2402 ± 761 | 2464 ± 704 | 2471 ± 826 |
1
DPA, docosapentaenoic acid; LC, long chain; MET, metabolic equivalent; MI, myocardial infarction.
2
Mean ± SD (all such values for continuous variables).
3
Matching variable.